By Alex Baldwin ( April 11, 2023, 5:31 PM BST) -- A Viatris subsidiary has argued that a London court should limit the damages it owes to rival Neurim over sales of its generic sleep aid to patients over the age of 55 suffering from a specific form of insomnia, marking the latest chapter in a global patent battle over the insomnia medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.